PharmaShots | Incisive News in 3 Shots

Subscribe Now

Post-Transplant

Takeda Receives the US FDA Advisory Committee's Recommendation for TAK-620 (maribavir) to Treat CMV Infection in Post-Transplant Recipients

Takeda Receives the US FDA Advisory Committee's Recommendation for TAK-620 (maribavir) to Treat CMV Infection in Post-Transplant R...

October 8, 2021

Takeda Report Results of TAK-620 (maribavir) in P-III SOLCTICE Trial for the Treatment of Post-Transplant Patients with Cytomegalovirus Infection

Takeda Report Results of TAK-620 (maribavir) in P-III SOLCTICE Trial for the Treatment of Post-Transplant Patients with Cytomegalo...

February 15, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us